Sign in

CIK 0001661053

  • Non-accelerated filer
  • Smaller reporting company

enVVeno Medical Corp

Sign in to watch
Ticker
NVNO
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330936180
Phone
+1 949-261-2900
Business address
70 DOPPLER, IRVINE, CA, 92618
Former names
Hancock Jaffe Laboratories, Inc.
  1. 4 Exercise or conversion Director acquired 1,041 shares (option exercise)
  2. 4 Exercise or conversion Director acquired 1,041 shares (option exercise)
  3. 4 Open-market buy Director bought 7,751 shares at $6.14 ($47,591)
  4. 4 Open-market buy Director bought 1,000 shares at $3.85 ($3,850)
  5. 4 Open-market buy Chief Executive Officer bought 2,500 shares at $3.80 ($9,500)
  6. 4 Grant or award Chief Executive Officer acquired 200,000 shares (grant or award)
  7. 4 Grant or award SVP & Chief Medical Officer acquired 100,000 shares (grant or award)
  8. 4 Grant or award Chief Financial Officer acquired 50,000 shares (grant or award)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Open-market buy CEO bought 2,000 shares at $7.43 ($14,860)
  14. 4 Exercise or conversion Director acquired 388 shares (option exercise)
  15. 4 Open-market buy CEO bought 2,000 shares at $7.87 ($15,740)
  16. 4 Exercise or conversion Director acquired 1,042 shares (option exercise)
  17. 4 Exercise or conversion Director acquired 1,042 shares (option exercise)
  18. 4 Open-market buy Director bought 1,300 shares at $7.70 ($10,010)
  19. 4 Open-market buy Director bought 2,000 shares at $6.25 ($12,500)
  20. 4 Open-market buy SVP & Chief Medical Officer bought 1,600 shares at $5.90 ($9,440)

Page 3 of 6 · 113 filings